Presentation - Zorevunersen Regulatory Alignment & Phase 3 Plans

Stoke Therapeutics Inc. published this content on January 07, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on January 07, 2025 at 13:26 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]